Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1199_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword for Benign Anorectal Disorders
- •Preface 1
- •Preface 2
- •1.5 Nerve Supply of Anal Canal and Rectum
- •1.6 Anorectal Spaces
- •Bibliography
- •2: Physiology of Defecation
- •2.1 Normal Defecation
- •2.1.2 Reservoir
- •Contents
- •1: Surgical Anatomy of Anal Canal and Rectum
- •1.1 Rectum
- •1.1.1 Relations
- •1.2 Anal Canal
- •1.2.1 Inner Lining
- •Bibliography
- •3: Hemorrhoids
- •3.1 Introduction
- •3.3.1 Vascular Hemorrhoids
- •3.3.2 Mucosal Hemorrhoids
- •3.3.3 Internal Hemorrhoids
- •3.3.4 External Hemorrhoids
- •3.4 Symptoms
- •3.4.1 Bleeding
- •3.4.2 Protrusion
- •3.4.3 Pain
- •3.4.4 Discharge and Irritation
- •3.4.5 Anemia
- •3.4.6 Painful Mass in the Anal Region
- •3.5 Clinical Examination
- •3.5.1 Digital Rectal Examination
- •3.5.2 Endoscopic Examination
- •3.6 Treatment
- •3.6.2 Medical Treatment
- •3.6.3.1 Injection Sclerotherapy
- •3.6.3.2 Rubber Band Ligation
- •3.6.3.3 Cryotherapy
- •3.6.3.4 Infrared Coagulation (IRC)
- •3.6.3.4.1 Complications
- •3.6.3.6 Direct Current Therapy
- •3.6.4 Surgical Treatment
- •3.6.4.2 Closed Hemorrhoidectomy (Ferguson)
- •3.6.4.3 White Head (Submucosal) Hemorrhoidectomy
- •3.6.4.4 Laser Hemorrhoidectomy
- •3.6.4.5 LigaSure Hemorrhoidectomy
- •3.6.4.6 Hemorrhoidectomy by Ultrasonic Scalpel (HUS)
- •3.6.4.6.1 Mechanism
- •3.6.4.6.2 Coaptive Coagulation
- •3.6.4.6.3 Cavitation Effect
- •3.6.4.6.4 Technique
- •3.6.4.8 Doppler-Guided Hemorrhoidal Artery Ligation (DGHAL)
- •3.6.4.8.1 Procedure
- •3.6.4.8.2 Postoperative Complications
- •3.6.4.8.3 Results
- •3.7.1 Pain
- •3.7.2 Urinary Retention
- •3.7.3 Postoperative Bleeding
- •3.7.4 Wound Infection
- •3.7.5 Fecal Impaction
- •3.7.6 Stenosis
- •3.7.7 Recurrence
- •3.7.8 Incontinence
- •3.7.9 Other Late Complications
- •3.8 Special Situations
- •3.8.1 Thrombosed Hemorrhoids
- •3.8.2 Strangulated Hemorrhoids
- •3.8.3 Anorectal Varices and Portal Hypertension
- •3.8.4 Pregnancy
- •3.8.5 Crohn’s Disease and Ulcerative Colitis
- •3.8.6 Immunocompromised Patients
- •3.8.7 Coagulation Disorders
- •3.8.8 Fissure
- •3.8.9 Sepsis
- •Conclusion
- •Bibliography
- •4: Anal Fissure
- •4.1 Introduction
- •4.2 Epidemiology
- •4.4 Pathology
- •4.5 Etiopathogenesis
- •4.5.1 Microtrauma to Anal Canal Mucosa
- •4.5.2 Anal Sphincteric Spasm
- •4.5.3 Anal Mucosal Ischemia
- •4.5.4 Trauma During Childbirth
- •4.5.5 Other Causes of Secondary Anal Fissure
- •4.6 Clinical Features
- •4.7 Differential Diagnosis
- •4.8 Management
- •4.8.2.1 Medical Management
- •4.8.2.2.3 Fissurectomy
- •4.8.2.2.4 Anal Dilatation or Stretch (Lord’s Procedure)
- •4.8.2.2.5 V-Y Mucosal Advancement Flap
- •4.8.2.2.6 Internal Anal Sphincterolysis
- •4.8.2.2.7 Direct Current Treatment
- •4.8.3 Recurrence
- •4.8.4 Special Situations
- •4.9 Prevention
- •Conclusion
- •Bibliography
- •5: Perianal Sepsis and Fistula
- •5.1 Introduction
- •5.2 Anatomy
- •5.3 Epidemiology and Etiology
- •5.4.1 Anorectal Abscess
- •5.4.2 Anal Fistula
- •5.5 Diagnosis
- •5.5.1 Anorectal Abscess
- •4.8.2.1.1 Chemical Sphincterotomy
- •4.8.2.1.2 Topical Nitroglycerine
- •4.8.2.1.3 Topical Diltiazem (2 %)
- •4.8.2.1.4 Topical Nifedipine (0.3 %)
- •4.8.2.1.5 Topical Bethanechol
- •4.8.2.1.6 Botulinum Toxin
- •4.8.2.1.8 Minoxidil
- •4.8.2.2 Surgical Management
- •4.8.2.2.1 Internal Sphincterotomy
- •4.8.2.2.2 Fissurotomy and Posterior Sphincterotomy
- •5.5.2 Anal Fistulas
- •5.5.3 Special Studies
- •5.5.3.1 Sigmoidoscopy and Colonoscopy
- •5.5.3.2 Fistulography
- •5.5.3.3 Endoanal Ultrasonography
- •5.5.3.4 Computed Tomography (CT) Scan
- •5.5.3.5 Magnetic Resonance Imaging (MRI)
- •5.5.3.6 Anorectal Manometry
- •5.5.3.7 Fistuloscopy
- •5.6 Treatment
- •5.6.1 Anorectal Abscess
- •5.6.2 Horseshoe Abscess
- •5.6.3 Abscess and Primary Fistulotomy
- •5.6.4 Fistula-in-Ano
- •5.6.4.1 Advancement Flap
- •5.6.4.2 Fibrin Glue
- •5.6.4.3 Seton
- •5.6.4.4 Anal Fistula Plug
- •5.6.4.5 Ligation of Intersphincteric Fistula Tract (LIFT)
- •5.6.4.6 Video-Assisted Anal Fistula Treatment (VAAFT)
- •5.6.4.7 Autologous Adipose-Derived Stem Cell
- •5.6.4.8 Fistulectomy and Fistulotomy
- •5.6.4.9 Fistulectomy with Primary Sphincter Reconstruction
- •5.6.5 Intersphincteric Fistula-in-Ano
- •Conclusion
- •Bibliography
- •6: Pilonidal Disease
- •6.1 Introduction
- •6.2 Etiology
- •6.2.1 Theory of Acquired Origin
- •6.3 Clinical Features
- •6.4 Differential Diagnosis
- •6.5 Investigations
- •6.6 Treatment
- •6.6.1 Conservative Treatment
- •6.6.2 Operative Procedures
- •6.6.2.1 Simple Incision of Abscess
- •6.6.2.3 Excision With or Without Wound Closure
- •6.6.2.4 Bascom I Technique
- •6.6.2.6 Vacuum-Assisted Closure (VAC)
- •6.7 Prevention of Recurrence
- •6.8 Summary
- •Bibliography
- •7: Rectovaginal Fistulas
- •7.1 Introduction
- •7.2 Etiology
- •7.2.1 Congenital
- •7.2.2 Acquired
- •7.2.2.1 Child Birth
- •7.2.2.2 Diverticular Disease
- •7.2.2.4 Malignancies
- •7.2.2.5 Radiation Therapy
- •7.2.2.6 Operative Trauma
- •7.3.1 Size
- •7.3.2 Location and Etiology
- •7.3.3 Anatomy
- •7.3.3.1 Pelvic Enterovaginal Fistula
- •7.3.3.2 High Rectovaginal Fistula
- •7.3.3.3 Midzone Rectovaginal Fistula
- •7.3.3.4 Low Rectovaginal Fistula
- •7.3.3.5 Suprasphincteric and Transsphincteric Anovaginal Fistula
- •7.4 Clinical Presentation
- •7.5 Diagnosis
- •7.5.2 Anorectal Manometry
- •7.5.3 Neurophysiologic Testing
- •7.5.4 Vaginography
- •7.5.5 Barium Enema
- •7.5.6 Computed Tomography (CT) Scan
- •7.5.7 Endoanal Ultrasonography (EAUS)
- •7.5.8 Magnetic Resonance Imaging (MRI)
- •7.5.9 Endoanal MRI
- •7.6 Management
- •7.6.1 Medical Management
- •7.6.2 Surgical Treatment
- •7.6.2.1 Transanal Approaches
- •7.6.2.1.1 Mucosal Advancement Flap Repair
- •7.6.2.1.2 Transanal Sleeve Advancement Flap (TSAF)
- •7.6.2.2 Transvaginal Approaches
- •7.6.2.2.1 Transvaginal Inversion Repair
- •7.6.2.3 Transperineal Approaches
- •7.6.2.3.1 Simple Fistulotomy
- •7.6.2.3.2 Fistulotomy with Perineoproctotomy with Layered Closure
- •7.6.2.3.3 Perineal Repair with Levatoroplasty
- •7.6.2.4 Transsphincteric Approach
- •7.6.2.5 Repair with Biological Agents
- •7.6.2.6 Tissue Transfer Procedures
- •7.6.2.6.1 Gracilis Transfer
- •7.6.2.6.2 Martius Flap Repair
- •7.6.2.7 Transabdominal Approaches
- •7.6.2.8 Fistula Division
- •7.6.2.8.1 Coloanal Sleeve Reconstruction
- •7.6.2.8.2 Bricker Patch
- •7.6.2.8.3 Stoma
- •7.6.2.9 Laparoscopic Repair
- •7.7 Complications
- •7.7.1 Complications of Local Repairs
- •7.7.1.1 Bleeding
- •7.7.1.2 Infection
- •7.7.1.3 Urinary Retention
- •7.7.1.4 Recurrence
- •7.7.2 Complications of Abdominal Repairs
- •7.7.2.1 Bleeding
- •7.7.2.2 Infection
- •7.7.2.3 Enterocutaneous Fistula
- •7.7.2.4 Recurrence
- •Bibliography
- •8: Anorectal Injuries
- •8.1 Introduction
- •8.2 Etiology
- •8.2.1 Trauma
- •8.2.1.1 Blunt Anorectal Trauma
- •8.2.1.2 Penetrating Anorectal Trauma
- •8.2.1.3 Blast Injury
- •8.2.2 Anorectal Foreign Bodies
- •8.2.3 Obstetric Injury
- •8.2.4 Iatrogenic Injuries
- •8.2.5 Sexual Assault
- •8.3 Diagnosis of Anorectal Trauma
- •8.3.1 Unstable Patient
- •8.3.2 Stable Patient
- •8.4 Grade of Injury
- •8.5 Surgical Strategy
- •8.5.1 Technical Points in Surgery
- •8.5.2 Anorectal Foreign Bodies
- •8.5.4 Iatrogenic Anorectal Injuries
- •8.5.5 Closure of Colostomy
- •8.6 Outcome
- •8.6.1 Complications
- •8.6.2 Mortality
- •Conclusion
- •Bibliography
- •9: Anal Incontinence
- •9.1 Introduction
- •9.2 Anatomy of the Anal Sphincter Complex
- •9.3 Causes of Incontinence
- •9.3.1 Trauma
- •9.3.2 Neurological Conditions
- •9.3.3 Diarrheal States
- •9.3.4 Congenital Disease
- •9.3.5 Pelvic Floor Denervation
- •9.3.6 Aging
- •9.3.7 Miscellaneous
- •9.4 Clinical Evaluation
- •9.4.1 Medical History
- •9.4.2 Examination
- •9.4.3 Investigations
- •9.4.3.1 Manometry
- •9.4.3.2 Measurement of Sphincter Strength
- •9.4.3.3 Anal Sphincter Electromyography (EMG)
- •9.4.3.4 Anal Ultrasound
- •9.4.3.5 Balloon Proctography and Defecography
- •9.4.3.7 Endoscopy
- •9.4.3.8 Pudendal Nerve Motor Latency (PNML)
- •9.5.1 Conservative Treatment
- •9.5.1.1 Diet
- •9.5.1.2 Pharmacological Treatment
- •9.5.1.3 Bowel Management
- •9.5.1.4 Physical Treatment
- •9.5.1.5 Biofeedback
- •9.5.1.6 Faradic Stimulation
- •9.5.2 Surgical Treatment
- •9.5.2.1 Thiersch Operation
- •9.5.2.2 Repair of Obstetrical Injuries
- •9.5.2.4 Restoration of the Anorectal Angle
- •9.5.2.5 Muscular Graft
- •9.5.2.5.1 Gluteoplasty
- •9.5.2.5.2 Graciloplasty
- •9.5.2.5.2.1 Adynamic Graciloplasty
- •9.5.2.5.2.2 Dynamic Graciloplasty
- •9.5.2.6 Sacral Nerve Stimulation (SNS)
- •9.5.2.8 The FENIX™ Continence Restoration System
- •9.5.2.9 Miscellaneous Procedures
- •9.5.2.9.1 Smooth Muscle Plasty
- •9.5.2.9.2 Reinforcement of the Occlusion Mechanism
- •9.5.2.9.3 Secca Procedure
- •9.5.2.9.4 Injectable Agents
- •9.5.2.9.5 Colostomy
- •Bibliography
- •10: Complete Rectal Prolapse in Adults
- •10.1 Introduction
- •10.2 Etiology
- •10.3 Clinical Features
- •10.4 Diagnosis
- •10.5 Treatment
- •10.5.1 Abdominal Procedure
- •10.5.1.1 Suture Rectopexy
- •10.5.1.2 Prosthetic or Mesh Rectopexy
- •10.5.1.3 Posterior Mesh Rectopexy
- •10.5.1.4 Ripstein Procedure (Anterior Sling Rectopexy)
- •10.5.1.5 Rectopexy with Resection
- •10.5.1.6 Ventral Rectopexy
- •10.5.1.7 Laparoscopic Rectopexy
- •10.5.2 Perineal Procedure
- •10.5.2.1 Thiersch Procedure
- •10.5.2.2 Delorme Operation
- •10.5.2.3 Perineal Rectosigmoidectomy (Altemeier’s Procedure)
- •10.6 Comparison of Different Procedures and Approaches
- •10.7 Choice of Operation
- •10.8 Recurrent Prolapse
- •10.9 Summary
- •Bibliography
- •11: Pelvic Floor Dysfunction
- •11.1 Introduction
- •11.2 Anatomical Footprint for Pelvic Floor Surgical Navigation
- •11.3 Clinical Features
- •11.3.1 Urinary Continence
- •11.3.2 Bladder Storage/Sensation Symptoms
- •11.3.3 Voiding/Micturition Symptoms
- •11.3.4 Pelvic Organ Prolapse Symptoms
- •11.3.5 Sexual Dysfunction Symptoms
- •11.3.6 Anorectal Dysfunction Symptoms
- •11.3.7 Pelvic Pain Syndrome/Pudendal Neuralgia (Nantes Criteria)
- •11.3.8 Erectile Tissue Denervation (S2–S4) Symptoms
- •11.4 Evaluation for Pelvic Floor Dysfunction
- •11.4.1 Examination for Pelvic Organ Prolapse
- •11.4.2 Evaluation for Anorectal Dysfunction
- •11.4.3 Evaluation for Anorectal Incontinence
- •11.4.4 Evaluation for Functional Defecation Syndromes
- •11.4.4.4 Rule Out Slow-Transit Constipation
- •11.4.4.5 Imaging for Pelvic Floor Dysfunction with ODS
- •11.4.4.5.1 Dynamic Fluoroscopic Defecography
- •11.4.4.5.2 Anal Endosonography
- •11.4.4.5.3 Dynamic MRI Defecography
- •11.5 Causes of Anorectal Outlet Obstruction
- •11.5.1 Paradoxical Puborectalis Syndrome (PPR) or Anismus
- •11.5.2 Rectal Intussusception
- •11.5.3 Rectocele
- •11.5.4 Idiopathic Megarectum
- •11.6 Management of Pelvic Floor Dysfunction
- •11.6.1 Surgery for ODS: Stapled Transanal Resection Rectopexy (STARR)
- •11.6.1.1 Operative Procedure
- •11.6.2 Pelvic Organ Prolapse Surgery with STARR (POPSTARR)
- •11.7 Descending Perineum Syndrome
- •11.8 Functional Pelvic Pain Disorders
- •11.8.1 Levator Ani Syndrome
- •11.8.2 Proctalgia Fugax
- •Bibliography
- •12: Perianal Dermatology
- •12.1 Introduction
- •12.3.1 Contact Dermatitis
- •12.3.2 Danthron Contact Dermatitis
- •12.3.4 Seborrheic Dermatitis
- •12.3.5 Atopic Dermatitis
- •12.3.6 Psoriasis
- •12.3.7 Lichen Simplex Chronicus
- •12.3.9 Hidradenitis Suppurativa
- •12.3.10 Crohn’s Disease (Synonym: Regional Ileitis)
- •12.3.12.1 Anal Fissures
- •12.3.12.2 Anal Fistula
- •12.3.12.3 Pilonidal Cyst/Sinus
- •12.3.12.4 Pruritus Ani
- •12.4 Infections
- •12.4.1 Folliculitis and Furunculosis
- •12.4.2 Streptococcal Dermatitis/Perianal Cellulitis
- •12.4.3 Perianal Abscess
- •12.4.4 Ecthyma Gangrenosum
- •12.4.5 Necrotizing Infections
- •12.4.6 Common Mycoses
- •12.4.7 Thread/Pinworms
- •12.4.8 Sexually Transmitted Diseases (STDs)
- •12.4.9 Miscellaneous Infections
- •12.5 Benign Tumors
- •12.5.1 Hemorrhoids
- •12.6 Premalignant Dermatoses and Frank Malignancies
- •12.6.1 Porokeratosis
- •12.6.2 Anal Intraepithelial Neoplasia
- •12.6.3 Carcinoma of the Anus
- •12.6.5 Miscellaneous Malignancies
- •12.8 Trauma in the Perianal Area
- •Conclusion
- •References
- •13: Benign Ulcers of the Anorectum
- •13.1 Introduction
- •13.2 Etiology
- •13.3 Signs and Symptoms
- •13.3.1 Diarrhea
- •13.3.2 Pain
- •13.3.3 Hemorrhage
- •13.3.4 Discharges
- •13.3.5 Pruritis or Itching
- •13.4 Diagnosis and Investigation
- •13.4.1 Endoscopy (Macroscopic and Microscopic Appearance)
- •13.4.2 Anorectal Function Tests
- •13.4.3 Radiological Investigation
- •13.4.3.1 Defecography
- •13.4.3.2 Barium Enema
- •13.4.3.3 Transrectal Ultrasound
- •13.4.4 Differential Diagnosis
- •13.5 Special Anorectal Ulcers
- •13.5.1 Anal Fissure
- •13.5.2 Hemorrhoidal Ulcer
- •13.5.3 Varicose Ulcer
- •13.5.4 Tubercular Ulcer
- •13.5.5 Syphilitic Ulcers
- •13.5.6 Dysenteric Ulceration
- •13.5.7 AIDS-Associated Anorectal Ulcers
- •13.5.8.1 Introduction
- •13.5.8.2 Clinical Features
- •13.5.8.4 Investigations
- •13.5.8.4.1 Sigmoidoscopy
- •13.5.8.4.2 Defecography
- •13.5.8.4.3 Barium Enema
- •13.5.8.4.4 Transrectal Ultrasonography (TRUS)
- •13.5.8.4.5 Anorectal Manometry
- •13.5.8.5 Differential Diagnosis
- •13.5.8.6 Management of SRUS
- •13.5.8.6.1 Conservative Treatment
- •13.5.8.6.2 Surgery
- •13.5.9 Suppository-Related Ulcers
- •13.5.10 Nicorandil-Induced Ulcers
- •13.6 Radiation-Induced Anorectal Ulcers
- •Bibliography
- •14: Benign Strictures of Anorectum
- •14.1 Introduction
- •14.2 Diagnosis
- •14.3 Etiology
- •14.3.1 Amoebic Proctocolitis
- •14.3.2 Tuberculous Stricture
- •14.3.3 Lymphogranuloma Venereum
- •14.3.4 Actinomycosis
- •14.3.6 Ischemic Colitis
- •14.3.7 Stricture Following Bowel Anastomosis
- •14.3.8 Stricture Following Anorectal Surgery
- •14.3.9 Strictures Following Traumatic Injuries
- •14.3.10 Postradiation Stricture
- •14.3.11 Endometriosis
- •14.4 Treatment Options
- •14.4.1 Diet and Medical Treatment
- •14.4.2 Dilatations
- •14.4.3 Surgical Treatment
- •14.4.3.1 Sphincterotomy
- •14.4.3.2 Anoplasty (Stricturoplasty)
- •14.4.3.3 Surgery for Rectal Strictures
- •14.4.3.4 Colostomy
- •14.5 Summary
- •Bibliography
- •15: Benign Tumors of the Anorectum
- •15.1 Introduction
- •15.2 Benign Tumors of Epithelial Origin
- •15.2.2 Keratoacanthoma
- •15.2.3.1 Etiopathogenesis
- •15.2.3.2 Epidemiological Facts
- •15.2.3.4 Investigations
- •15.2.3.5 Treatment
- •15.2.4 Preventive Measures
- •15.2.5.1 Serrated Polyps and Adenoma
- •15.2.6 Nonneoplastic Adenomas
- •15.2.6.1 Hyperplastic Polyp
- •15.2.6.3 Hamartomatous Polyps, Juvenile Polyp, and Retention Polyp
- •15.2.6.4 Lymphoid Hyperplasia and Lymphoid Polyp
- •15.3 Benign Mesenchymal Tumors
- •15.3.1 Lipoma
- •15.3.2 Fibroma
- •15.3.4 Leiomyoma
- •15.3.7 Hemangioma
- •15.3.8 Lymphangioma
- •15.4 Benign Exogenous, Extrinsic, and Miscellaneous Tumors
- •15.4.1 Barium Granuloma
- •15.4.2 Endometriosis
- •15.4.4 Sarcoidosis
- •15.4.5 Tuberculosis
- •Conclusion
- •Bibliography

60
P. Sheikh and P. Bajaj
5.6.4.4 Anal Fistula Plug
Champagne BJ et al. in 2006 published results of
treating fi stula using a biological plug derived
from the submucosa of porcine small intestine
(Surgisis from Cook Surgical) (Fig. 5.19 ). Its
components are collagen which provide strength,
proteoglycan (regulates growth factor activity),
elastin (provides elasticity), glycosaminoglycans
like heparin (promotes angiogenesis), and hyaluronic acid (prevents scarring and adhesions).
Adjacent cells are attracted. Capillary growth
delivers nutrients and allows more cells to enter.
Surgical site gets saturated by host cells replacing plug. An impressive success rate of 85 % in
46 patients followed up for a median period of
1 year has been reported (Champagne et al.
2006 ). Unfortunately, the same success rate
could not be replicated by most surgeons. It is
indicated for Crohn’s fi stula, patients with poor
sphincter function, and those unfi t for surgery.
The fi stula plug is inserted into the primary
opening of fi stula and is secured in place with
one or two stitches. A systematic review of cases
that used anal fi stula plug from 1995 to 2011 was
published in 2012 (O’ Riordan et al. 2012 ). This
revealed an overall healing rate for non-Crohn’s
fi stula to be around 54 %. One of the common
causes of failure was the extrusion of the plug in
almost 8.4 % of the cases. The healing rates in
Crohn’s fi stula were higher in most studies
reaching to almost 85 % (Schwandner et al.
2008 ). The Gore Bio-A® Fistula Plug is another
bioprosthetic plug which is used with similar
results ranging from 57.5 to 72.7 % (Ommer
et al. 2012 ; Ratto et al. 2012 ).
The main advantages of the bioprosthetic plug
are its safety, the incidence of incontinence is
very low, has low septic complications, and can
be repeated. However, using a plug increases the
cost of the surgery; the results may be inferior as
compared to the other standard procedures. It is
recommended for Crohn’s fi stula, patients with
poor sphincter function, and those unfi t for
surgery.
a
c
2
1
Mucosa
Submucosa
Internal Sphincter
External Sphincter
Side View
Fig. 5.19 Anal fi stula plug. ( a ) Surgisis® AFP™ anal fi stula plug. ( b ) Gore Bio-A® Fistula Plug. ( c ) Shows how to
suture the fi stula plug
Needle
b
3

5 Perianal Sepsis and Fistula
61
5.6.4.5 Ligation of Intersphincteric Fistula Tract (LIFT)
In 2007, Dr. Arun Rojanasakul fi rst published an
article on a total sphincter-saving procedure
which he termed as LIFT (ligation of intersphincteric fi stula tract). The procedure is quite simple
and consists of ligation of the fi stula tract in the
ab
intersphincteric space with curettage of the
remaining tract (Fig. 5.20 ). Rojanasakul’s initial
success rate was 94.4 % (Arun Rojanasakul et al.
2007 ). Subsequent studies have revealed a heal-
ing rate ranging from 68 to 83 % with an average
healing time from 6 to 7 weeks. The sample size
of these studies has been mostly small. Recently,
d
c
e
Fig. 5.20 LIFT technique. ( a , b ) Approach to intersphincteric space. ( c ). Fistula tract dissected and identifi ed. ( d )
Fistula tract ligated with Vicryl suture. ( e , f ) Fistula tract divided
f

62
P. Sheikh and P. Bajaj
two large series have been reported with a longer
follow-up. The series from Singapore reported 93
cases with a mean follow-up of 23 weeks. At the
end of 1 year, 78 % of their patients were cured
(Tan et al. 2011 ). A very important observation,
which was made in this study, was that the median
time to recurrence was 22 weeks. Thus, studies
with longer follow-up are needed to validate the
success or failure of a particular procedure. The
second large series of 93 cases has been reported
from Minnesota with a median follow-up of
19 months (Wallin et al. 2012 ). The results, how-
ever, were not very encouraging (40 % after the
fi rst LIFT procedure). The success rate improved
to 57 % after subsequent surgery. Rojanasakul
has stressed the need to follow the proper steps in
the LIFT technique as described by him,
water- tight ligation of the intersphincteric tract
being the most important step to ensure success
of the procedure. The marked difference in the
success rates in the two series also raises the
issue of surgical competence, which needs to be
considered.
Modifi cations of the LIFT technique have been
described to increase its success rate. One of the
causes of failure of the LIFT technique has been
attributed to inadequate clearance of all unhealthy
granulation tissue/sepsis in the distal tract. A
recent study of 41 cases compared the LIFT technique with LIFT along with the additional step of
coring fi stulectomy, which was done from the
external opening till the anal sphincter (Siripong
Sirikurnpiboon et al.
2013 ). No signifi cant differ-
ence in success rate was noted (85 % vs. 81 %).
Another study of 41 patients to determine whether
adding an advancement fl ap to the LIFT technique would help to increase the success rate
revealed an overall healing rate of 71 % (Van
Onkelen et al. 2012 ). Both the above series were
small and revealed no signifi cant incontinence.
Reinforcing the LIFT with a bioprosthetic graft
has been used to signifi cantly improve the success
rate of LIFT (75– 94 %) (Ellis 2010 and Ellis et al.
2010 ). This has been reported from a single center
and not much data is otherwise available. Another
small study of 13 patients published recently
showed a primary healing of 68.8 % with the BioLIFT procedure (Tan and Lee 2013 ). LIFT, due to
its simplicity and safety, is becoming the popular
technique for transsphincteric fi stula worldwide.
It gives less postoperative pain and heals wound
faster with early return to normal work. However,
it should be done in selected patients. Further
reports are awaited to confi rm the long-term
results and feasibility of the technique in various
types of fi stula.
5.6.4.6 Video-Assisted Anal Fistula Treatment (VAAFT)
In 2006, Dr. P. Meinero described the videoassisted anal fi stula treatment (VAAFT) technique
for fi stula-in-ano. This technique basically consists of an initial diagnostic phase which is performed by an 18-cm long rigid fi stuloscope with
an 8° angled eyepiece, which is passed through
the external opening (Fig. 5.21 ). Glycine–manni-
tol solution is used to open the fi stula tract. The
fi stuloscope is advanced till the internal opening.
a
b
Fig. 5.21 VAAFT. ( a ) Instrumentation for VAAFT. ( b )
Fistuloscope passed through the external opening—
illumination seen at the internal opening

5 Perianal Sepsis and Fistula
63
In the operative phase, a unipolar electrode is used
to cauterize the lining of the fi stula tract, and an
endobrush is used to extract the necrotic material.
A semicircular or linear stapler is then used to seal
off the internal opening. Alternately, a cutaneous
or mucosal fl ap can be used. At the end of the
surgery, synthetic cyanoacrylate is injected to
reinforce the staple/suture line. He published his
results in 2012 (Meinero and Mori 2012 ). The
procedure was performed in 136 patients over a
period of 5 years. In a mean follow-up of
13 months, primary healing was achieved in 72
(73.5 %) patients at the end of 3 months. At the
end of 1 year, 87.1 % of fi stulas had healed. In his
series, only six patients had a suprasphincteric fi stula. It is not very clear as to how many of those
six recurred. The main advantage of this technique is sphincter preservation, thereby very low
incidence of incontinence, and the postoperative
pain is minimum. However, no mention is made
about how to manage tracts which are longer than
18 cm, tracts which have no external openings,
and tracts which are acutely curved. Adding
another procedure, like advancement fl ap to
VAAFT, may improve the results (Schwandner
2013 ). Since this is a relatively new procedure, it
would be advisable to look out for some more evidence before one can give a verdict.
5.6.4.7 Autologous Adipose-Derived Stem Cell
Autologous adipose-derived stem cells (20 million) derived from liposuction have been used to
treat fi stula-in-ano. They can be used in combination with fi brin glue. The results at 1 year vary
from 50 to 71 % (Garcia-Olmo et al.
2009 ;
Herreros et al. 2012 ). The results may be superior
as compared to the use of fi brin glue alone. There
were no signifi cant side effects with minimal
morbidity after this procedure. However, the low
success rates and the as yet experimental nature
of this procedure still prelude it from being
recommended as a standard treatment for
fi stula-in-ano.
5.6.4.8 Fistulectomy and Fistulotomy
Fistulectomy is recommended for low anal fi stulas, as the success rate is high with this procedure
and with minimal risk of incontinence. The success rates can be as high as 93 to 100 % in experienced hands (Tozer et al.
2013 ; Cariati 2013 ).
The incontinence is usually minor and ranges
from 11.5 to 20 %. It is also indicated in epithelialized tracts and tracts surrounded by dense
fi brous tissue. A tract is cannulated and excised
in toto leaving the wound to heal by secondary
intention or closed primarily (Figs. 5.22a–d ).
Alternatively, a coring technique may be used in
which circular incision is made around the external opening which is held in Allis forceps. The
wound is deepened and tract is cored out up to
internal opening (Fig. 5.23 ). The internal defect
is closed by approximating the mucosa and
internal sphincter or by advancement fl aps if the
mucosal defect cannot be closed by approximation. The defect in the internal and external
sphincter can be closed with 2/0 Vicryl. The technique gives excellent results with rapid healing
and acceptable rates of incontinence and recurrence if properly executed. There is less wound
discharge and soiling, minimal fi brosis, and minimal anal deformity. However, tuberculosis and
Crohn’s should be ruled out before undertaking
this procedure and repair of inner defect by
mucosal fl ap.
For low transsphincteric or intersphincteric
fi stula and those of recent origin, the fi stulous
tract can be laid open as fi stulotomy (Fig. 5.24 )
with all unhealthy granulation tissue curetted
out. The external wound can either be left open
to heal by secondary intention or closed primarily or partially to reduce the defect and healing
time.
All side tracks should be looked for, laid open,
and curetted out. Counter-incisions may be
needed for complex fi stulas with long and multiple external tracts (Fig.
5.25 ). The internal open-
ing along with adjacent part of internal sphincter
and anal gland should be excised.
Division of external and internal sphincters
can be undertaken safely up to dentate line in
young healthy individuals, but one should be
careful in elderly frail patients with low sphincter
tone. In such patients, either a seton or some
other conservative technique is used to reduce the
chances of developing incontinence.

64
a
b
P. Sheikh and P. Bajaj
d
c
Fig. 5.22 Fistulectomy. ( a ) Fistula being excised. ( b ) Wound with shelving edges after fi stulectomy. ( c ) Healing
healthy wound 2 wks after fi stulectomy. ( d ) Primary closure after fi stulectomy
5.6.4.9 Fistulectomy with Primary Sphincter Reconstruction
Cutting seton has a high success rate, but one
has to deal with the higher rate of incontinence
that goes with it. The reason for the incontinence is that even though the seton cuts slowly,
thus enabling the sphincter ends not to retract
much, it still does cut the anal sphincter. If one
were to cut the sphincter and suture it primarily,
the success rates would be still high, while
reducing the incontinence rates. Based on this
principle, two recent papers showed a success
rate as high as 95.8 % with an insignifi cant
change in the continence scores (Ratto et al.
2013 ). Continence and anal manometry results
were improved in incontinent patients and were
not jeopardized in continent ones (Arroyo et al.
2012 ). Fistulotomy with sphincter reconstruc-

5 Perianal Sepsis and Fistula
65
Fig. 5.23 Coring technique for fi stulectomy
Fig. 5.25 Complex fi stula with long and multiple tracts
Fig. 5.24 After fi stulotomy, underlying granulations to
be curetted
tion is an especially suitable technique for
incontinent patients with recurrent fi stulas. The
primary sphincter repair enhances wound healing and reduces the hospital stay. The author
also follows this procedure for transsphincteric
fi stula with similar satisfying results.
5.6.5 Intersphincteric Fistula-in-Ano
Most of the procedures described above are useful for transsphincteric fi stulas. Low intersphincteric fi stulas typically may have an external
opening close to the anal verge and can be easily
treated by a simple fi stulotomy. High intersphincteric fi stulas are the most diffi cult to diagnose
Fig. 5.26 Supralevator tract extending to the preperitoneal space. The drains are positioned in the preperitoneal
space
because they do not have any external fi ndings.
They also have the highest recurrence rate and
take the longest to heal. Their symptoms are similar to those of fi ssure-in-ano, and it is not uncommon to fi nd these patients being treated both
medically and surgically for fi ssure-in-ano. One
should suspect an intersphincteric tract especially
when the patient has additional symptoms of discharge per rectum, soiling of undergarments, and
pain over the sacrococcygeal area. These fi stulas
can extend superiorly to the supralevator space
and still further to the preperitoneal and retroperitoneal spaces. The later two circumstances
may be misdiagnosed as peritonitis, and the
patient may be subjected to a laparotomy (Sheikh
P and Baazka A 2014 ) (Fig. 5.26 ).

66
P. Sheikh and P. Bajaj
Treatment for high intersphincteric fi stulas
has not been mentioned much in the literature. A
simple approach is to excise the internal opening
along with the underlying indurated affected anal
gland and to curette the rest of the tract. In a tract
which extends to the preperitoneal space, an
additional extraperitoneal abdominal approach
will be needed to curette this part of the tract.
These cases will have to be closely followed up
and wound irrigated with saline till they heal
completely. Sometimes, they may require additional curettage of the wounds under anesthesia
to get rid of the hypergranulation tissue that usually occurs in these cases. A short high intersphincteric fi stula can also be cored out
completely by an intersphincteric dissection and
the wound can then be primarily closed. This
does require some technical expertise, but can
shorten the postoperative period and make it very
easy to manage.
5.6.6 Anal Fistula in Special
Conditions
It is important to subject all excised tissue during
surgery to histological examination. This will
enable the surgeon to diagnose and treat other
uncommon causes of anal fi stula like tuberculosis, Crohn’s disease, and malignancy.
Anal fi stula due to Crohn’s disease is not as
common in the east as it is in the west. One
should suspect Crohn’s fi stula when the patient
has corresponding abdominal complaints. There
may be multiple draining sinuses and scarring in
the perianal area (Fig.
may have a preexisting intestinal disease. The
diagnosis is confi rmed on histology of the fi stula
tact. The main treatment in Crohn’s fi stula unlike
a cryptoglandular fi stula is medical rather than
surgery. Surgery is carried out as a supportive
procedure. Usually, a long-term seton is the safest option. This reduces perianal drainage and
pain without damaging the sphincter and minimizes the risk of future abscesses arising from
the fi stula track (Faucheron et al. 1996 ).
Fistulotomy for low fi stulas can be attempted.
Success rates will still be lower than in patients
5.27 ). Many of the patients
Fig. 5.27 Crohn’s fi stula
without Crohn’s disease (Schwartz et al.
2001 ).
There may be some role of anal fi stula plugs in
these fi stulas. Infl iximab is a murine chimeric
monoclonal antibody against tumor necrosis
factor-α. It is the only medical treatment proven
to lead to a reduction in the number of perianal
fi stulas in patients with Crohn’s disease (Present
et al. 1999 ). However, in practice, recurrence
after cessation is common.
Tuberculosis causes anal fi stula in 4–5 % of
the cases in the east. A preoperative chest x-ray is
necessary to rule out pulmonary tuberculosis
which is a commoner form of tuberculosis. It is
very diffi cult to clinically diagnose tuberculosis
fi stula preoperatively. The classical description
of the presence of multiple openings is more
often not true. Once histology reveals tuberculosis, it has to be treated as extrapulmonary tuberculosis, and the complete treatment may extend
from 9–12 months. These patients heal very rapidly once they are started on antituberculosis
treatment.
Malignancy arising from an anal fi stula tract is
rare. It is more common to see an anorectal
malignancy being diagnosed as an anal fi stula.
One can have a long-standing fi stula where
malignancy can develop in one part of the tract.
In the author’s experience, most of these fi stulas
are mucinous adenocarcinoma and should be
treated accordingly.
Anal fi stula in HIV patients needs to be particularly investigated for tuberculosis. The surgical management of these patients essentially
remains the same as non-HIV patients, except

5 Perianal Sepsis and Fistula
67
that one should ensure a good immunologic
status of the patient before surgery. They should
preferably be managed by some conservative
method.
Conclusion
A clear understanding of the anorectal anatomy, along with the knowledge of etiopathogenesis of anal fi stula, is of paramount for any
surgeon who treats it. In the last decade, new
surgeries have been added to the existing list
of procedures for anal fi stula. This has only
added to the number of procedures available
and may confuse the surgeon further with the
choice of operations available. Advancement
fl aps are useful in closing big mucosal defects.
Seton placements have been widely used in
the past and are still being used either as draining setons or as cutting setons in patients
where incontinence is threatened. Newer technique like LIFT, due to its simplicity and conservative nature, is proving to be increasingly
popular especially for low transsphincteric
fi stula. The anal fi stula plug has low success
rate except for Crohn’s disease. VAAFT and
autologous adipose-derived stem cells are new
techniques with not much data available to
opine about their success. Fibrin glue has
moderate success rate with simple low fi stula,
but poor results with high or complex anal fi stula. It should be used in patients unfi t for surgery and those with low sphincter tone like
fi stula plug. Cutting seton and fi stulotomy
have high success rate, but one has to take
steps to avoid or reduce rate of incontinence.
Primary suturing after fi stulectomy for transsphincteric fi stula appears to take care of this
incontinence and is something to look out for
in the future. Recurrence after draining an
anorectal abscess can be decreased, if fi stulotomy is done primarily by experienced surgeons in selected patients. Most of the studies
available are small in size, and there are no
randomized trials available to compare the
success of various procedures against equivalent types of fi stula. At present, there is no evidence to recommend or condemn any single
procedure. Similar views were echoed in the
Cochrane database systematic review which
was published in 2010 . There is certainly no
ideal surgery as yet for anal fi stula. The sur-
geon has to decide about the type of procedure
based on his experience, patient factors, and
the nature of fi stula he or she is dealing with.
There is certainly a lot of scope for more stud-
ies in this area, but the diversity and the com-
plex nature of the disease probably prevent
one to undertake such a study.
Bibliography
Arroyo A, Pérez-Legaz J, Moya P, et al. Fistulotomy and
sphincter reconstruction in the treatment of complex
fi stula-in-ano: long-term clinical and manometric
results. Ann Surg. 2012;255(5):935–9.
Beets Tan RG, Beets GL, van Der Hoop AG, et al.
Preoperative MR imaging of anal fi stulas: does it
really help the surgeon? Radiology. 2001;218:75.
Benjelloun EB, Jarrar A, El Rhazi K, et al. Acute abscess
with fi stula: long-term results justify drainage and fi s-
tulotomy. Updates Surg. 2013;65(3):207–11.
Brook I, Frazier EH. The aerobic and anaerobic bacteriol-
ogy of perirectal abscess. J Clin Microbiol. 1997;35:
2974–6.
Cariati A. Fistulotomy or seton in anal fi stula: a decisional
algorithm. Updates Surg. 2013;65(3):201–5.
Champagne BJ, O’Connor LM, Ferguson M, et al.
Effi cacy of anal fi stula plug in closure of cryptoglan-
dular fi stulas: long-term follow-up. Dis Colon Rectum.
2006;49(12):1817–21.
Choen S, Burnett S, Bartram CI, et al. Comparison
between anal endosonography and digital examination
in the evaluation of anal fi stulae. Br J Surg. 1991;78:
445–7.
Cirocco WC, Reilly JC. Challenging the predictive accu-
racy of Goodsall’s rule for anal fi stula. Dis Colon
Rectum. 1992;35:537.
Dajani AS, Taubert KA, Wilson W, et al. Prevention of bac-
terial endocarditis. Recommendations by the American
Heart Association. Circulation. 1997;96:358–66.
Ellis CN. Outcomes with the use of bioprosthetic grafts to
reinforce the ligation of the intersphincteric fi stula
tract (BioLIFT procedure) for the management of
complex anal fi stulas. Dis Colon Rectum. 2010;
53(10):1361–4.
Ellis CN, Rostas JW, Greiner FG. Long-term outcomes
with the use of bioprosthetic plugs for the manage-
ment of complex anal fi stulas. Dis Colon Rectum.
2010;53(5):798–802.
Faucheron J, Saint-Marc O, Guibert L, Parc R. Long-term
seton drainage for high anal fi stulas in Crohnʼs
disease-A sphincter-saving operation?. Diseases of the
Colon & Rectum. 1996;39(2):208–211.

68
P. Sheikh and P. Bajaj
Fazio VW. Complex anal fi stulae. Gastroenterol Clin
North Am. 1987;16:93.
Frudinger A, Halligan S, Bartram CI, et al. Female anal
sphincter: age-related differences in asymptomaticm
volunteers with high frequency endoanal US. Radiology.
2002;224:417–23.
Garcia-Olmo D, Herreros D, Pascual I, et al. Expanded
adipose-derived stem cells for the treatment of
complex perianal fi stula: a phase II clinical trial. Dis
Colon Rectum. 2009;52(1):79–86.
Gordon PH, Nivatvongs S. Principles and practice of
surgery for the colon, rectum and anus. Quality
Medical Publishing; New York. 1999. p. 241–283
Grace RH, Harper IA, Thompson RG. Anorectal sepsis:
microbiology in relation to fi stula-in-ano. Br J Surg.
1982;69:401–3.
Halligan S, Stoker J. Imaging of fi stula in ano 1.
Radiology. 2006;239:18–33.
Hamadani AB, Haigh PI, Liu IA, et al. Who is at risk for
developing chronic anal fi stula or recurrent anal sepsis
after initial perianal abscess? Dis Colon Rectum.
2009;52:217–21.
Hammond TM, Grahn MF, Lunniss PJ. Fibrin glue in the
management of anal fi stulae. Colorectal Dis. 2004;
6(5):308–19.
Henrichsen S, Christiansen J. Incidence of fi stula-in-ano
complicating anorectal sepsis: a prospective study. Br
J Surg. 1986;73:371–2.
Herreros MD, Garcia-Arranz M, Guadalajara H, et al.
Autologous expanded adipose-derived stem cells for
the treatment of complex cryptoglandular perianal
fi stulas: a phase III randomized clinical trial (FATT 1:
fi stula Advanced Therapy Trial 1) and long-term
evaluation. Dis Colon Rectum. 2012;55(7):762–72.
Isbister WH. A simple method for the management of
anorectal abscess. Aust N Z J Surg. 1987;57:771–4.
Jacob TJ, Perakath B, Keighley MR. Surgical intervention
for anorectalfi stula. Cochrane Database Syst Rev.
2010; (5):CD006319.
Jarrar A, Church J. Advancement fl ap repair: a good
option for complex anorectal fi stulas. Dis Colon
Rectum. 2011;54(12):1537–41.
Johnson E, Gaw JU, Armstrong DN. Role of anorectal
fi stuloscopy in evaluating complex anorectal fi stulas.
Dis Colon Rectum. 2005;48:631.
Jones J, Tremaine W. Evaluation of perianal fi stulas in
patients with crohn’s disease. MedGenMed. 2005;
7(2):16.
Kuijpers HC, Schulpen T. Fistulography for fi stula-in-
ano: is it useful? Dis Colon Rectum. 1985;28:103–4.
Law PJ, Bartram CI. Anal endosonography: technique
and normal anatomy. Gastrointest Radiol. 1989;14(1):
349–535.
Leng Q, Jin HY. Anal fi stula plug vs mucosa advancement
fl ap in complex fi stula-in-ano: a meta-analysis. World
J Gastrointest Surg. 2012;27(4(11)):256–61.
Lim CH, Shin HK, Kang WH, et al. The use of a staged
drainage seton for the treatment of anal fi stulae or fi stulous abscesses. J Korean Soc Coloproctol. 2012;28(6):
309–14.
Llera JL, Levy RC. Treatment of cutaneous abscess: a
double-blind clinical study. Ann Emerg Med. 1985;
14:15–9.
Loungnarath R, Dietz DW, Mutch MG, et al. Fibrin glue
treatment of complex anal fi stulas has low success
rate. Dis Colon Rectum. 2004;47(4):432–6.
Lunniss PJ, Armstrong P, Barker PG, et al. Magnetic
resonance imaging of anal fi stulae. Lancet. 1992;340:
394–6.
Macfi e J, Harvey J. The treatment of acute superfi cial
abscesses: a prospective clinical trial. Br J Surg. 1977;
64:264–6.
Malik AI, Nelson RL, Tou S. Incision and drainage of
perianal abscess with or without treatment of anal fi s-
tula. Cochrane Database Syst Rev. 2010;(7):CD006827.
Meinero P, Mori L. Video-assisted anal fi stula treatment
(VAAFT): a novel sphincter-saving procedure for
treating complex anal fi stulas. Tech Coloproctol.
2012;16(1):111.
Mitalas L, Gosselink M, Zimmerman D, Schouten R.
Repeat Transanal Advancement Flap Repair: Impact
on the Overall Healing Rate of High Transsphincteric
Fistulas and on Fecal Continence. Diseases of the
Colon & Rectum. 2007;50(10):1508–1511.
Mizrahi N, Wexner SD, Zmora O, et al. Endorectal
advancement fl ap: are there predictors of failure? Dis
Colon Rectum. 2002;45(12):1616–21.
Nelson R. Anorectal abscess fi stula: what do we know?
Surg Clin North Am. 2002;82(6):1139–51.
Ommer A, Herold A, Joos A, et al. Fistula plug in the
treatment of high anal fi stulas–initial results from a
German multicenter-study. Ger Med Sci. 2012;10:13.
O’Riordan JM, Datta I, Johnston C, Baxter NN. A sys-
tematic review of the anal fi stula plug for patients with
Crohn’s and non-Crohn’s related fi stula-in-ano. Dis
Colon Rectum. 2012;55(3):351–8.
Parks AG, Gordon PH, Hardcastle JD. A classifi cation of
fi stula in ano. Br J Surg. 1976;63:1.
Present DH, Rutgeerts P, Targan S, et al. Infl iximab for the
treatment of patients with Crohn’s disease. N Engl J
Med. 1999;340:1398–405.
Quah HM, Tang CL, Eu KW, et al. Meta-analysis of
randomized clinical trials comparing drainage alone vs
primary sphincter-cutting procedures for anorectal
abscess-fi stula. Int J Colorectal Dis. 2006;21(6):602–9.
Ramanujam PS, Prasad ML, Abcarian H, et al. Perianal
abscesses and fi stulas. A study of 1023 patients. Dis
Colon Rectum. 1984;27(9):593–7.
Ratto C, Litta F, Parello A, et al. Gore Bio-A® Fistula
Plug: a new sphincter-sparing procedure for complex
anal fi stula. Colorectal Dis. 2012;14(5):e264–9.
Ratto C, Litta F, Parello A. Fistulotomy with end-to-end
primary sphincteroplasty for anal fi stula: results from
a prospective study. Dis Colon Rectum. 2013;56(2):
226–33.
Read DR, Abcarian H. A prospective survey of 474
patients with anorectal abscess. Dis Colon Rectum.
1979;22:566–8.
Rojanasakul A, Pattanaarun J, et al. Total anal sphincter
saving technique for fi stula-in-ano; The ligation of

5 Perianal Sepsis and Fistula
69
intersphincteric fi stula tract. J Med Assoc Thai. 2007;
90(3):581–6.
Schwandner O. Video-assisted anal fi stula treatment
(VAAFT) combined with advancement fl ap repair in
Crohn’s disease. Tech Coloproctol. 2013;17(2):221–5.
Schwandner O, Stadler F, Dietl O, et al. Initial experience
on effi cacy in closure of cryptoglandular and Crohn’s
transsphincteric fi stulas by the use of the anal fi stula
plug. Int J Colorectal Dis. 2008;23(3):319–24.
Schwartz DA, Pemberton JH, Sandborn WJ. Diagnosis
and treatment of perianal fi stulas in Crohn disease.
Ann Intern Med. 2001;135:906–18.
Sheikh P, Baazka A. Management of fi stula in ano- the
current evidence. Indian J Surg. 2014;76(6):482–6.
Sirikurnpiboon S, Burin A, Jivapaisarnpong P. Ligation of
intersphincteric fi stula tract and its modifi cation:
results from treatment of complex fi stula. World
J Gastrointest Surg. 2013;5(4):123–8.
Sonoda T, Hull T, Piedmonte MR, Fazio VW. Outcomes
of primary repair of anorectal and rectovaginal fi stulas
using the endorectal advancement fl ap. Dis Colon
Rectum. 2002;45(12):1622–8.
Spencer JA, Chapple K, Wilson D, et al. Outcome after
surgery for perianal fi stula: predictive value of MR
imaging. AJR Am J Roentgenol. 1998;171:403–6.
Stewart MP, Laing MR, Krukowski ZH. Treatment of
acute abscesses by incision, curettage and primary
suture without antibiotics: a controlled clinical trial.
Br J Surg. 1985;72:66–7.
Sultan AH, Kamm MA, Hudson CN, et al. Anal sphincter
disruption during vaginal delivery. N Engl J Med.
1993;329:1905–11.
Takayuki T, Makoto M, Yoshiaki T, et al. Evidence based
treatment strategy of anorectal sepsis and anal fi stula.
Nippon Doncho Konmonbyo Gakki Zasshi. 2008;
61(7):364–77.
Tan KK, Lee PJ. Early experience of reinforcing the
ligation of the intersphincteric fi stula tract procedure
with a bioprosthetic graft (BioLIFT) for anal fi stula.
ANZ J Surg. 2013;84(4):280–3.
Tan KK, Tan IJ, Lim FS, et al. The anatomy of failures
following the ligation of intersphincteric tract tech-
nique for anal fi stula: a review of 93 patients over 4
years. Dis Colon Rectum. 2011;54(11):1368–72.
Tozer P, Sala S, Cianci V, et al. Fistulotomy in the tertiary
setting can achieve high rates of fi stula cure with an
acceptable risk of deterioration in continence.
J Gastrointest Surg. 2013;17:1960–5.
van Onkelen RS, Gosselink MP, Schouten WR. Is it
possible to improve the outcome of transanal
advancement fl ap repair for high transsphincteric
fi stulas by additional ligation of the intersphincteric
fi stula tract? Dis Colon Rectum. 2012;55(2):163–6.
Vasilevsky CA, Gordon PH. The incidence of recurrent
abscesses or fi stula-in-ano following anorectal suppu-
ration. Dis Colon Rectum. 1984;27:126–30.
Vial M, Parés D, Pera M, Grande L. Faecal incontinence
after seton treatment for anal fi stulae with and without
surgical division of internal anal sphincter: a system-
atic review. Colorectal Dis. 2010;12(3):172–8.
Wallin UG, Mellgren AF, Madoff RD, Goldberg SM. Does
ligation of the intersphincteric fi stula tract raise the bar
in fi stula surgery? Dis Colon Rectum. 2012;55(11):
1173–8.
Whiteford MH, Kilkenny J, Hyman N, et al. Practice
parameters for the treatment of perianal abscess and
fi stula-in-ano (revised). Dis Colon Rectum. 2005;48:
1337–42.
Yeung JM, Simpson JA, Tang SW, et al. Fibrin glue for
the treatment of fi stulae in ano-a method worth stick-
ing to? Colorectal Dis. 2010;12(4):363–6.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
